BREAKING NEWS: Pinnacle Medicines raises $89M for oral peptide development - Meet Peptide Pioneers in April

BREAKING NEWS: FDA Approves Johnson & Johnson's IL-23' ICOTYDE™ receptor - Meet J&J and More in April

BREAKING NEWS: Endevica Announces Spinout of Kalohexis to Advance First- and Best-in-Class Therapeutics Harnessing the Melanocortin System to Treat Obesity and Metabolic Diseases - Meet Peptide Pioneers in April

BREAKING NEWS: Daiichi Sankyo to collaborate with Meddenovo's AI-powered Mexa technology to advance the de novo design of cyclic peptides - Learn More in April

BREAKING NEWS: Unnatural Products raise a further $45M in Series B financing for a new class of medicines built on synthetic macrocyclic peptides - meet them in April

Industry News: Novo Nordisk teams with Langer-founded biotech Vivtex for oral obesity drugs - meet them in April

Industry News: Novartis signs macrocyclic deal with Unnatural Products - meet them in April

Industry News: Zonsen PepLib Biotech Enters Global R&D Collaboration and License Agreement with Lilly - meet them in April

Industry News: PeptiDream Announces Achievement Milestone with Johnson & Johnson - meet them in April

Joshua Schwochert

Co-founder & Chief Scientific Officer Unnatural Products

Seminars

Tuesday 28th April 2026

Spotlight Case Study 1: How Can AI Complement Empirical Methods in Peptide Drug Discovery?

View all Speakers

View Event Brochure

Joshua Schwochert

Joshua Schwochert

Seminars

Venue

Map

Contact

Join Our Team

About Us

Explore Our Products

Stay Connected

Search

Organized By